Dianthus Therapeutics (DNTH) Leases: 2022-2025
Historic Leases for Dianthus Therapeutics (DNTH) over the last 3 years, with Sep 2025 value amounting to $1.3 million.
- Dianthus Therapeutics' Leases rose 271.02% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 271.02%. This contributed to the annual value of $1.6 million for FY2024, which is 152.52% up from last year.
- As of Q3 2025, Dianthus Therapeutics' Leases stood at $1.3 million, which was down 5.22% from $1.4 million recorded in Q2 2025.
- In the past 5 years, Dianthus Therapeutics' Leases registered a high of $25.4 million during Q1 2022, and its lowest value of $352,000 during Q3 2024.
- For the 3-year period, Dianthus Therapeutics' Leases averaged around $924,556, with its median value being $698,000 (2023).
- As far as peak fluctuations go, Dianthus Therapeutics' Leases tumbled by 97.08% in 2023, and later soared by 271.02% in 2025.
- Quarterly analysis of 4 years shows Dianthus Therapeutics' Leases stood at $814,000 in 2022, then declined by 24.45% to $615,000 in 2023, then surged by 152.52% to $1.6 million in 2024, then soared by 271.02% to $1.3 million in 2025.
- Its Leases was $1.3 million in Q3 2025, compared to $1.4 million in Q2 2025 and $1.4 million in Q1 2025.